|
WELCOME! to the web-site of ECCH, the representative platform for the homeopathy profession in Europe made up of 26 member professional associations in 22 EU, EEA and CEE countries.
More introductory information about ECCH is available under the Public Services section of this site.
To find a list of national professional associations throughout Europe click on ECCH Members.
 ECCH is pleased to support the first European Congress for Integrative Medicine - the first European congress on integrated healthcare open to the participation of all health care practitioners in Europe.
For more information including the programme and how to register please visit:
http://www.ecim-congress.org
Latest News:
15 August
New trial shows provers react more to medicinal source materials than to placebos
ABTRACT:
Journal of Psychopharmacology, Vol. 22, No. 5, 543-552 (2008)
DOI: 10.1177/0269881108091259
Homeopathic pathogenetic trials produce more specific than non-specific symptoms: results from two double-blind placebo controlled trials
H. Walach
School of Social Sciences and European Office of the Samueli Institute for Information Biology, University of Northampton, Northampton, UK, harald.walach@northampton.ac.uk, Academic Section on the Evaluation of Complementary Medicine, Institute for Environmental Medicine and Hospital Epidemiology, University Hospital Freiburg, Freiburg, Germany
H. Möllinger
Health Center Socrates, Güttingen, Switzerland
J. Sherr
Malvern, Worcester, UK
R. Schneider
Department of Human Sciences, University Osnabrück, Osnabrück, Germany
We conducted two parallel, blinded homeopathic pathogenetic trials conducted at two different sites to determine whether symptoms reported by healthy volunteers were significantly different for homeopathic remedies than for placebos. Study 1 used a two-armed design, testing ozone against placebo. Study 2 used a three-armed design, testing ozone and iridium against placebo. We found significantly more remedy-specific symptoms in provers taking ozone or iridium than in provers taking placebo in the three-armed trial and in both trials pooled for ozone and placebo. We, therefore, conclude that homeopathic remedies produce more symptoms typical for a remedy than non-typical symptoms. The results furthermore suggest a somewhat non-classical pattern because symptoms of one remedy appear to be mimicked in the other trial arm. This might be indicative of entanglement in homeopathic systems.
Key Words: non-specific symptoms • pathogenetic trial • placebo
The article can be accessed at:
http://jop.sagepub.com/cgi/content/abstract/22/5/543
28 June
The Evidence Base for Homeopathy: accumulating evidence
The British Medical Journal of Clinical Evidence recently summarised the state of evidence for 2500 commonly used treatments used daily in the UK National Health Service in the following way 'Of around 2500 treatments covered 13% are rated as beneficial, 23% likely to be beneficial, 8% as trade off between benefits and harms, 6% unlikely to be beneficial, 4% likely to be ineffective or harmful, and 46%, the largest proportion, as unknown effectiveness'
Ref: http://clinicalevidence.bmj.com/ceweb/about/knowledge.jsp
In contrast with this a recent paper published in the open access publication the International Journal for High Dilution Research presents an overview of the evidence base for homeopathy. The paper reveals high levels of evidence for the clinical effectiveness of homeopathy and increasingly high levels of evidence for the fact that high dilutions have an effect such that the evidence base for homeopathy compares extremely well with conventional treatments. The author concludes that homeopathy should be included as a viable patient care option within medical practice and as part of national health care provision.
Reference: Scientific framework of homeopathy: Evidence-based Homeopathy
Author: Dr Michel Van Wassenhoven
Abstract: This paper aims at considering all important aspects of the scientific framework of homeopathic practice, looking at the levels of scientific evidence of each aspect in an objective way, through an extensive review of literature. Levels of evidence considered are: I) existence of meta-analyses and/or systematic positive reviews of literature; IIa) multiple positive randomized controlled trials (RCTs); IIb) some positive RCTs; IIIa) positive multiple cohorts studies; IIIb) positive studies with some cohorts; IV) opinion of experts (clinical and daily practice cases). The conclusions are clear: homeopathy must stay within the framework of medical practice, and it is even a necessity for public health.
Reference: http://www.feg.unesp.br/~ojs/index.php/ijhdr/article/view/286
For news items from previous months go to the main menu News section.
|
|
|
Public Services If you are a member of the public seeking brief information about homeopathy then you should go to our introductory page.
If you are seeking the services of a qualified and registered homeopath in your particular country then please see if there is a member association of ECCH in your country in the ECCH Members section.
For information about ECCH itself please click here. |
|
|
For Homeopaths As well as the introductory pages for the members of the public we have developed a number of other web-pages of interest to homeopaths in this section of the site.
Forthcoming seminars and conferences are listed on our News and Events Page. For any further information on Homeopathy and the Homeopathy Profession please feel free to contact us at ecch@homeopathy-ecch.org |
|
|
